Sir Arthur Thomson Trust lecture series - Professor Monika Stoll
- Arthur Thomson Hall (ATH) in the Medical School Building
- Medical and Dental Sciences
The Trustees of the Sir Arthur Thomson Trust and Professor David Adams are delighted to announce the prestigious Sir Arthur Thomson Lecture entitled “The Tip of the Iceberg: On the genetic and genomic basis of arrhythmogenic disorders” will be given by Professor Monika Stoll, visiting guest lecturer.
The lecture will be followed by a drinks/buffet reception. Please register if you'd like to attend the reception for catering purposes.
The lecture is open to all who are interested, including students.
Professor Stoll graduated from University of Giessen, Germany, where she received her Diploma in Biology in 1991, before finishing a PhD in Pharmacology in 1995 at University of Heidelberg. She then assumed a postdoctoral fellowship at the Medical College of Wisconsin, USA, where she discovered her interest in complex genetics and genomics. In 2003, she became Professor and Director of the Division Genetic Epidemiology at the Leibniz-Institute for Arteriosclerosis Research, and starting 2014, at the Institute of Human Genetics of the University of Münster, Germany.
In October 2013 she assumed a part-time position as Visiting Professor in Cardiovascular Genetics at Maastricht University. In 2015, she was appointed as Extraordinary Professor of Genetic Epidemiology and Statistical Genetics. In October 2016, she was appointed as Vice-Rector for Research of the University of Muenster.
Professor Stoll is engaged in research in complex genetics and genetic epidemiology particularly relating to cardiovascular diseases and inflammation. Current research projects address the genetic and genomic basis of arrhythmogenic diseases and heart failure. She is involved in a number of large research networks, such as the EU-funded Horizon2020 consortium, and is responsible for all aspects of next generation sequencing approaches and the analysis thereof in the context of the pathogenesis of atrial fibrillation. In addition, her group is running a core facility for genetics and genomics which supports high-density arrays for SNP, CNV, methylome and transcriptome analysis, next generation sequencing and a (bio)informatics infrastructure for management of large data sets.